Joe Biden Managed Metastatic Prostate Cancer
The 83-year-old is undergoing treatment for stage 4 disease that has spread to his bones.
Updated on Sept. 29, 2026 in Cancer
Joe Biden, age 83, continues to receive medical treatment for stage 4 prostate cancer. The diagnosis was first reported in May 2025.
Why it matters
Prostate cancer that has metastasized to the bone requires ongoing, long-term management to control disease progression and maintain quality of life. This level of care remains a primary focus for patients living with late-stage diagnoses.
Joe Biden received a stage 4 prostate cancer diagnosis in May 2025, characterized by a Gleason score of 9 and confirmed bone metastasis. The condition is currently managed as a chronic, long-term state.
The players
Joe Biden
The 83-year-old is currently managing stage 4 metastatic prostate cancer.
Ashley Biden
The 45-year-old shared a public photograph of the patient in September 2026.
The details
Metastatic prostate cancer occurs when cancer cells spread from the prostate to other parts of the body, in this case, the bone. Management typically involves systemic therapies designed to suppress testosterone, which fuels the cancer, alongside targeted treatments aimed at bone protection and symptom management.
Timeline
May 2025: Joe Biden received his prostate cancer diagnosis.
September 2026: Ashley Biden posted a photograph featuring Joe Biden.
Health Landscape
The clinical management of stage 4 prostate cancer has shifted toward chronic care models that focus on quality of life and long-term suppression. This approach reflects a broader trend of treating metastatic disease as a manageable condition through sustained medical intervention.
Individuals with a personal or family history of prostate cancer should discuss the value of regular screening and symptomatic monitoring with their physician. Early detection remains the most effective tool for preventing the disease from progressing to a metastatic state.
The takeaway
Advanced prostate cancer requires a coordinated, long-term treatment plan to manage the disease effectively. Patients should work closely with their oncology team to track symptoms and adjust therapies as needed over time.
Further reading
For more information on the progression and management of advanced disease, visit Cancer.
